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In Practice/Vet Record print summary 
 
Gp’s Guide to Pseudomonas Otitis 
Natalie Barnard & Aiden Foster  
INTRODUCTION. 
 
Pseudomonas is not usually isolated from normal dog’s ears; it can account 
for up to 35% of cases of otitis externa and or media (Cole and others 1998) 
and is challenging to manage. 
 
HISTORY & CLINICAL SIGNS 
 
Dogs often present with an acute onset painful ear with a large amount of 
purulent exudate, one or both ears can be affected. The ear canal may be 
ulcerated. In chronic cases lichenification, hyperpigmentation and excoriation 
of the pinna may be present. Other clinical signs that may be seen or reported 
include: 
• Head shaking 
• Odour 
• Head tilt 
• Pain when opening the mouth or swallowing 
• There may be other signs of skin disease, such as pedal pruritus. 
• Vestibular signs – seen in some cases of otitis media 
• Loss of hearing 
A general physical examination and dermatological examination should be 
performed; it is important to check for any neurological deficits (head tilt, 
facial paralysis, nystagmus etc.) in cases where otitis media is suspected. 
Look for other signs of generalised skin disease.  
 
DIAGNOSTIC TESTS 
Cytology 
Cytology should be performed in all cases of otitis externa. It is often better 
tolerated than otoscopy and will reveal rod shaped organisms and 
inflammatory cells. In some cases there is a mixed infection so coccoid 
bacteria and/or Malassezia may be seen but the Pseudomonas is the critical 
organism.  
 
Otoscopy 
This can be very challenging to perform in conscious patients. Often sedation 
or anaesthesia is required. It may be difficult to view the tympanic 
membrane.  
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Culture and sensitivity 
Swabs should be sent for culture and sensitivity in all cases of Pseudomonas 
otitis. The sensitivity results may not be relevant when using topical 
treatments because the concentrations of drugs applied to the ear are much 
greater than those tested and may still be effective.  
 
Treatment/management options   
 
Treatment requires dedication; in some chronic cases it is not unusual for 
treatment to take 6 – 8 weeks with revisits every two weeks to monitor   
progress.  
 
The aims of treatment are: 
1) Eliminate the Pseudomonas 
a. Topical treatment remains the treatment of choice due to the poor 
blood supply to the ear canal. However, the exception to this 
rule is when cases have neurological signs associated with 
their otitis media. In these cases, topical treatment should 
generally be avoided as it may exacerbate the neurological 
signs.  
 
b. The following topical ear products are available in the U.K. and 
may be suitable to treat cases of Pseudomonas otitis: 
 
i. Marbofloxacin  (Aurizon®: Vetoquinol, 
Marbodex®: Norbrook           Laboratories) 
ii. Orbifloxacin (Posatex®: MSD) 
iii. Gentamicin  (Otomax®; MSD, Easotic®; Virbac) 
iv. Polymixin B  (Surolan®; Elanco, Aurimic: Animalcare) 
None of these treatments is licensed to be used in an ear with a 
ruptured ear drum.  
c. Polymixin B should be effective in managing cases of 
Pseudomonas otitis, however, in the authors’ experience in the 
U.K, success with this treatment seems to be limited.  
 
d. Tris-EDTA (TRizAural®; Dechra) is available as an alkaline 
solution. Even if culture and sensitivity indicate that a Gram-
negative bacterium is resistant in vitro to a certain antibiotic, pre-
treatment with Tris-EDTA may make the organism sensitive to the 
antibiotic in vivo. This product should be applied as a pre-
treatment solution 20 to 30 minutes prior to applying topical 
antibiotic treatment, such as fluoroquinolones or gentamicin 
(Buckley and others 2013). 
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e. Silver sulphadiazine (Flamazine cream®: Smith and Nephew). This 
product is not licensed for use in animals in the U.K.  This is not 
ototoxic and so can be used in cases of otitis media. It is 
empirically suggested to mix 1.5 mls with 13.5 mls of saline, which 
is then mixed well to make a uniform suspension (Foster & DeBoer 
1998). Apply 1-2 mls to the affected ear twice daily.   
 
f. There are currently no topical products licensed to treat otitis 
media in the dog. Below are some suggested treatments that can 
be used when the tympanic membrane is ruptured. These 
products are off license. Clients should be warned of possible 
adverse effects and sign a consent form for off-label use. Regular 
monitoring is vital.  
 
i. TrizAural pre-flush then one of the following 
ii. Injectable enrofloxacin solution (Baytril®; Bayer 2.5%): 
water for injection in a 1 : 4 ratio.  This is the author’s 
preferred way to use this product. Instill 0.5-1 ml of the 
solution into the dog’s ear twice daily.  
iii. Flamazine® cream-suspension. 
 
2) Reduce the inflammation in the ear canal  
a. Glucocorticoids are the most effective way to reduce inflammation 
and hyperplasia given systemically or topically. Typical oral doses for 
prednisolone range from 0.5-1 mg/kg once daily for a minimum of 
10-14 days.  
 
3) Provide analgesia 
a. Glucocorticoids are not an analgesic. Often opiate-based 
analgesics are used if required. E.g. Tramadol (2-5 mg/kg three 
times daily) or paracetamol-codeine (PARDALE-V). 
 
4) Clean the ear  
This will enhance the effectiveness of the antimicrobial agents. 
There are many ear cleaning products on the market and most 
have a good antibacterial action. An ear flush under general 
anaesthesia is recommended in most cases of Pseudomonas otitis.  
  
Challenges and considerations  
 
• Managing owners’ expectations 
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o Advise it may take at least 6 – 8 weeks to improve/resolve the 
problem and that if this has been a recurrent problem investigating 
the underlying cause (TABLE 1) will be essential to preventing 
relapses in the future. 
• Owner compliance 
o Consider using a syringe to apply cleaner to the ear.  
o Always demonstrate the use of ear cleaners and drops to clients  
• Infection recurs when treatment is discontinued 
o Usually happens when treatment is discontinued too early, always 
aim to treat for at least 7 – 10 days past cytological cure. 
o Primary, predisposing and perpetuating factors may not have been 
adequately addressed. 
o Often ear cleaning will need to be continued as maintenance therapy.  
• Follow up is vital 
o Re-examination and cytology should be performed every 10-14 days.  
• Consider surgery   when: 
o Medical treatment fails or is not possible due to client or patient 
factors 
Bottom line/conclusion  
 
Pseudomonas otitis is perhaps the most challenging infection of the ear to 
manage. It is important that we treat these cases aggressively at first 
presentation and address any predisposing, primary, secondary or 
perpetuating factors that may be present. Topical treatment is the best way 
to manage cases without neurological signs. Successful management of these 
cases is more likely with a dedicated owner and regular re-examinations with 
cytology is vital. 
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TABLE 1 Predisposing, primary, secondary and perpetuating factors for otitis 
Predisposing factors – these make the chance of developing otitis externa 
more likely by changing the environment in the ear canal, but alone will not 
cause otitis externa. These are explored in more detail elsewhere (Paterson 
2016). Examples include: 
• Conformation – e.g. pendulous ear canals, hairy ear canals, stenotic ear 
canals (occur naturally in some breeds such as the Shar Pei) 
• Excessive moisture in the ear – as a result of swimming, excessive use 
of ear cleaners 
• Inappropriate treatment – which may traumatise the ear canal 
Primary factors – these factors can directly case otitis externa 
• Ectoparasites – Otodectes, demodicosis. 
• Foreign bodies – grass seed 
• Allergic skin disease (adverse food reaction, atopic dermatitis).  
o Atopic dermatitis is the most common cause of otitis 
externa in the dog 
• Endocrinopathies  - hyperadrenocorticism and hypothyroidism 
• Immune-mediated disease – e.g. pemphigus foliaceus, juvenile cellulitis 
• Keratinisation defects – e.g. sebaceous adenitis 
• Immunosuppression – possible secondary to neoplasia or chemotherapy 
• Neoplasia within the ear canal 
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Secondary factors – these factors contribute to or cause pathology in an 
abnormal ear, but will not create disease in normal ears, examples include 
yeast and bacterial overgrowth. 
Perpetuating factors – these are the changes (anatomically or 
physiologically) that occur in an ear when chronic otitis is present and make 
it harder to manage medically. Examples include: 
• Stenosis of the ear canal 
• Ulceration  
• Epidermal and glandular hyperplasia 
• Otitis media  
 
